F Boehlen
Overview
Explore the profile of F Boehlen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
399
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bertrand G, Blouin L, Boehlen F, Levine E, Minon J, Winer N
Arch Pediatr
. 2019 Mar;
26(3):191-197.
PMID: 30827773
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a potentially devastating disease, seen in 1/800-1000 neonates. FNAIT is the most common cause of early-onset isolated severe neonatal thrombocytopenia in maternity wards....
2.
Martillotti G, Boehlen F, Robert-Ebadi H, Jastrow N, Righini M, Blondon M
J Thromb Haemost
. 2017 Aug;
15(10):1942-1950.
PMID: 28805341
Summary: Background Massive pulmonary embolism (PE) during pregnancy or the postpartum period is a rare but dramatic event. Our aim was to systematically review the evidence to guide its management....
3.
Boehlen F, Burkhard P, Momjian S, Fontana P
Haemophilia
. 2017 May;
23(3):e246-e248.
PMID: 28520203
No abstract available.
4.
Blondon M, Harrington L, Boehlen F, Robert-Ebadi H, Righini M, Smith N
Thromb Res
. 2016 Jul;
145:151-6.
PMID: 27421192
Objective: To characterize the risk of postpartum venous thromboembolism (VTE) associated with body-mass-index (BMI) in both pre-pregnancy and at delivery, and with gestational weight gain (GWG). Methods: In a population-based,...
5.
Lavigne-Lissalde G, Aya A, Mercier F, Roger-Christoph S, Chauleur C, Morau E, et al.
J Thromb Haemost
. 2015 Jan;
13(4):520-9.
PMID: 25594352
Background: Case reports on recombinant human factor VIIa (rhuFVIIa) use in women with severe postpartum hemorrhage (PPH) showed encouraging results, but no randomized controlled trial (RCT) is available. Patients And...
6.
Blondon M, Harrington L, Righini M, Boehlen F, Bounameaux H, Smith N
J Thromb Haemost
. 2014 Oct;
12(12):2002-9.
PMID: 25279442
Background: Venous thromboembolism (VTE) is a major contributor of maternal morbidity and mortality. Whether maternal race/ethnicity is associated with the risk of postpartum VTE remains unclear. Methods And Results: We...
7.
Ortigueira M, Capanna F, Boehlen F, Martinez de Tejada B, Savoldelli G
Anaesth Intensive Care
. 2014 Sep;
42(5):668-70.
PMID: 25233184
No abstract available.
8.
Brandt K, Fickentscher C, Boehlen F, Kruithof E, de Moerloose P
J Thromb Haemost
. 2014 Mar;
12(5):779-91.
PMID: 24612386
Background: The antiphospholipid antibody syndrome (APS) is an autoimmune disease associated with arterial or venous thrombosis and/or recurrent fetal loss and is caused by pathogenic antiphospholipid antibodies (aPLA). We recently...
9.
Casini A, Boehlen F, Lecompte T, de Moerloose P
Rev Med Suisse
. 2013 Mar;
9(372):315-8, 320.
PMID: 23469399
Polycythaemia vera, essential thrombocythemia and primary myelofibrosis are stem cell-derived clonal haemopathies classified in the group of myeloproliferative neoplasms. Their clinical course may be complicated by both arterial and venous...
10.
de Moerloose P, Casini A, Boehlen F, Fontana P
Rev Med Suisse
. 2013 Feb;
9(369):104-7.
PMID: 23409645
Physicians are confronted with many new antithrombotic drugs, either antiplatelet agents or new oral anticoagulants (NOAC). Targets of NOAC are specific (either anti-IIa or antiXa) and clinical studies have shown...